Three deletions of the thalassemia gene a belong to the intermediate type of thalassemia, in which the patient develops significant anemia, which is more severe.
A thalassemia is generally divided into stationary, standard, intermediate and severe a thalassemia. When differentiated according to genotype, if the abnormality of the three a genes is present, it is intermediate thalassemia. Patients may develop the disease at one year of age and usually have mild to moderate anemia, which may be accompanied by jaundice, hepatosplenomegaly, and skeletal changes.
Specific treatments include suspension red blood cell transfusions and iron removal medications (Deferasirox).
If the patient has three deletions of the thalassemia gene A and the above symptoms, it is recommended to consult a doctor in time, complete the relevant examinations and take appropriate treatment measures under the doctor’s guidance.